Search

everythinglearnresearchcommunity

for

Search:↓

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Mutations in certain receptors can cause diseases and offer new treatment options.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Innovative cosmetics could safely change hair color by targeting biological hair pigmentation processes.

Activin A and follistatin control when hair cells develop in mouse ears.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Dutasteride and finasteride affect different cell types differently.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Analog 23 is a promising compound for prostate cancer treatment.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

A protein called FERONIA helps control root hair growth in response to cold and low nitrogen by activating nutrient-sensing pathways in a plant called Arabidopsis.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.